Protocol Design and Performance Benchmarks by Phase and by Oncology and Rare Disease Subgroups

BACKGROUND: Benchmark data characterizing protocol design practices and performance informs clinical trial design decisions and serves as important baseline measures for assessing protocol design behaviors and their impact during and post-pandemic. METHODS: Tufts CSDD, in collaboration with a workin...

Descripción completa

Detalles Bibliográficos
Autores principales: Getz, Kenneth, Smith, Zachary, Kravet, Marcy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373886/
https://www.ncbi.nlm.nih.gov/pubmed/35960455
http://dx.doi.org/10.1007/s43441-022-00438-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373886/
https://www.ncbi.nlm.nih.gov/pubmed/35960455
http://dx.doi.org/10.1007/s43441-022-00438-5

Ejemplares similares